Enavive, Injektionslösung

7680119090029 CH-11909 Injektionslösung
Enavive, Injektionslösung
Enavive, Injektionslösung
Enavive, Injektionslösung
1 / 3
google

Article details

Package size
6 x 2
Selling units
6
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
22/06/2023
Summary of Product Characteristics
Français
22/06/2023
Summary of Product Characteristics
Italien
22/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
11909
Drug name
Enavive, Injektionslösung
Galenic form
LSINJ
ATC Code
A11HA30
Authorization status
Z
Dispensing category
B
First authorization
27/03/1944
Authorization expiration date
31/12/9999
IT Number
07.02.3.
Domain
Human medicine
Field of application
Pantothensäure-Therapie

Package details

Description (FR)
ENAVIVE sol inj 500 mg/2ml 6 amp 2 ml
Description (DE)
ENAVIVE Inj Lös 500 mg/2ml 6 Amp 2 ml
Market launch
23/12/2011
Narcotic (BTM)
No

Other package sizes (3)

None
6x2 ML
GTIN: None
Not in V1
DEXPANTHENOL Bayer sol inj 500 mg/2ml 6 amp 2 ml
None None
GTIN: 7680119090012
Not in V1
BEPANTHEN sol inj 500 mg/2ml 6 amp 2 ml
None None
GTIN: 7680119090289
Not in V1